Jafron Biomedical Co Ltd (300529): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 14,97 Renminbi Yuan | 23,227 Renminbi Yuan | 14,73 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 24,115 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 798.605.275 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 2.011.817,981 | 2.677.320,709 | 1.922.348,169 | 2.491.439,432 | 2.675.454,459 | 1.950.780,489 | 1.431.819,39 | 1.016.508,791 | 718.491,13 | 543.640,52 | 508.905,176 | 370.937,548 | 303.587,592 | 250.620,619 | 194.982,813 |
Herstellungskosten | 428.504,855 | 520.255,498 | 390.888,981 | 440.362,414 | 402.121,211 | 287.999,471 | 197.442,96 | 154.489,672 | 113.939,491 | 87.359,732 | 78.731,978 | 56.729,814 | 49.501,703 | 43.862,183 | 34.511,396 |
Bruttoergebnis | 1.583.313,126 | 2.157.065,211 | 1.531.459,188 | 2.051.077,018 | 2.273.333,248 | 1.662.781,018 | 1.234.376,43 | 862.019,119 | 604.551,639 | 456.280,788 | 430.173,198 | 314.207,734 | 254.085,889 | 206.758,436 | 160.471,417 |
▸ Brutto-Marge | 78,7% | 80,57% | 79,67% | 82,32% | 84,97% | 85,24% | 86,21% | 84,8% | 84,14% | 83,93% | 84,53% | 84,71% | 83,69% | 82,5% | 82,3% |
Betriebliche Aufwendungen | 843.791,273 | 1.111.699,437 | 987.639,971 | 1.021.622,197 | 855.409,065 | 608.429,327 | 554.046,663 | 385.711,375 | 272.841,691 | 223.614,903 | 198.132,86 | 140.164,232 | 113.924,191 | 98.562,79 | 74.230,654 |
Operativer Gewinn/Verlust | 739.521,853 | 1.045.365,774 | 543.819,217 | 1.029.454,821 | 1.417.924,183 | 1.054.351,691 | 680.329,767 | 476.307,744 | 331.709,948 | 232.665,885 | 232.040,338 | 174.043,502 | 140.161,698 | 108.195,646 | 86.240,763 |
▸ Operative Marge | 36,76% | 39,05% | 28,29% | 41,32% | 53% | 54,05% | 47,52% | 46,86% | 46,17% | 42,8% | 45,6% | 46,92% | 46,17% | 43,17% | 44,23% |
Zinsen (Netto) | -39.040,275 | -33.223,88 | 32.673,102 | 16.748,878 | 13.243,077 | 27.528,135 | 9.380,417 | 5.281,065 | 7.073,477 | 5.947,585 | -50,031 | -37,867 | -38,202 | - | - |
▸ Zinsausgaben | 53.511,826 | 64.220,263 | 55.287,241 | 36.513,48 | 14.551,186 | 1.288,411 | 233,503 | 140,574 | 93,025 | 64,868 | 50,031 | 37,867 | 38,202 | - | - |
▸ Zinseinnahmen | 14.471,551 | 30.996,383 | 87.960,343 | 53.262,358 | 27.794,263 | 28.816,546 | 9.613,92 | 5.421,639 | 7.166,502 | 6.012,453 | - | - | - | - | - |
Andere Ausgaben | 40.354,48 | 5.177,704 | 55.472,25 | 29.395,696 | 23.949,681 | 49.931,786 | 18.428,132 | 8.451,894 | -1.354,278 | -2.845,863 | -7.832,5 | -17.108,932 | -11.787,727 | -12.279,725 | -4.612,523 |
Gewinn vor Steuern | 660.127,097 | 1.006.964,19 | 521.020,069 | 1.016.808,003 | 1.407.217,579 | 1.031.948,04 | 671.282,052 | 473.136,915 | 340.137,703 | 241.459,333 | 239.822,807 | 191.114,567 | 151.911,223 | 120.475,371 | 90.853,286 |
Steueraufwand | - | 192.777,811 | 95.296,913 | 135.862,904 | 211.376,133 | 158.951,761 | 102.588,623 | 72.191,45 | 55.685,758 | 39.340,842 | 39.381,768 | 31.066,373 | 25.126,666 | 20.451,08 | 15.091,213 |
Minderheitenanteil | 127.305,785 | -6.009,055 | -10.769,061 | -8.619,285 | -971,912 | -2.244,265 | -2.129,287 | -1.034,497 | 37,948 | - | - | - | - | - | - |
Nettogewinn/-verlust | 532.821,312 | 820.195,434 | 436.492,217 | 889.564,384 | 1.196.813,358 | 875.240,544 | 570.822,716 | 401.979,962 | 284.413,997 | 202.118,491 | 200.441,039 | 160.048,194 | 126.784,557 | 100.024,291 | 75.762,073 |
▸ Netto-Marge | 26,48% | 30,63% | 22,71% | 35,7% | 44,73% | 44,87% | 39,87% | 39,55% | 39,58% | 37,18% | 39,39% | 43,15% | 41,76% | 39,91% | 38,86% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.